Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2023)

TransMedics (TMDX) has 2 years of Total Non-Current Liabilities data on record, last reported at $562.8 million in Q3 2023.

  • For Q3 2023, Total Non-Current Liabilities changed N/A year-over-year to $562.8 million; the TTM value through Sep 2023 reached $562.8 million, changed N/A, while the annual FY2022 figure was $89.8 million, N/A changed from the prior year.
  • Total Non-Current Liabilities reached $562.8 million in Q3 2023 per TMDX's latest filing, up from $545.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $562.8 million in Q3 2023 and bottomed at $89.8 million in Q4 2022.